Clinical Trials Browser

Phase 1/2 × INDUSTRY × pidilizumab × Clear all

NCT00966251 2012-10-23

Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Hepatocellular Carcinoma

Phase 1/2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular